Delivery Order SPE2DB24D2205-SPE2DB25FDZUF
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,225.87, is for the delivery of 4,568,577,881 units of the drug Nitazoxanide 500 mg tablets. The award has an ultimate completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop...
- This federal contract award, valued at $11,207.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567269176 NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product, with a completion date of February 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,132.66 firm fixed-price delivery order is for the supply of 4,566,904,791 units of the medication Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. There was no set-aside designation used for this award. AmerisourceBergen holds a...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Nitazoxanide 500 mg tablets, to the Defense Logistics Agency (DLA). The $2,515.38 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 8, 2023, with a completion date of August 9, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $22,072.38, is a delivery order for the supply of 4,566,087,677 units of the pharmaceutical product Nitazoxanide 500 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of October 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of nitazoxanide 500 mg tablets over a 2-year period ending in May 2024. The firm fixed-price contract has a ceiling value of $19,431.44 and was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) within the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,563.48 firm-fixed-price contract is for the supply of 4,567,278,099 tablets of the drug Nitazoxanide 500 mg. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award is for the delivery of NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 27, 2025, with a completion date of February 28, 2025. The contract has a ceiling value of $34,454.87 and is a Firm Fixed Price Delivery Order contract. The contract is not designated with a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,961.78 firm fixed-price delivery order is for the supply of 4,566,862,352 units of the drug Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of January 8, 2025 and was awarded on January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,743.79 firm fixed-price delivery order is for the supply of 4,567,202,446 units of the drug Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FDZUFDelivery Order
This federal contract award is for the delivery of 4,567,617,245 units of the pharmaceutical product Nitazoxanide 500 mg tablet. The contract, with a ceiling value of $42,938.91, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of March 19, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.9k | 3/18/25 |